Crohn's disease
Not recruitingStudy on Guselkumab for Healing in Crohn's Disease Patients
- Disease:Crohn's disease
- Substances:Guselkumab
Germany- Participants:18–64 years · 65+ years
- Substances:Guselkumab
- Sponsor:Janssen - Cilag International
Rare diseases
Investigational molecules
Locations
Back to Germany25 clinical trials in Dachau, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)
GermanyThe busiest research cities in the country
What the registry says about research in the country
Research focusing on respiratory syncytial virus (RSV) and chronic obstructive pulmonary disease, evaluating innovative treatment approaches and preventive measures.
Advanced trials investigating both preventive vaccines and therapeutic interventions for respiratory conditions.
Comprehensive studies addressing inflammatory bowel diseases, including breakthrough treatments for ulcerative colitis and Crohn's disease.
Multiple innovative treatments being evaluated to improve patient outcomes in inflammatory bowel conditions.
Critical research in atrial fibrillation and related cardiovascular conditions, exploring new therapeutic strategies and prevention methods.
Innovative approaches to cardiac care and stroke prevention in high-risk patients.
Advanced research in chronic lymphocytic leukemia, particularly focusing on high-risk patients with specific genetic markers.
Cutting-edge treatments targeting specific genetic mutations in blood disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.